INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 422m ago
HOUSE PTR21m ago
SEC 13F21m ago
ROBINHOOD CHAIN21m ago
Public company

AVITA Medical, Inc.

RCELCIK 0001762303

EDGAR filingsOpen in network
Price$16.59
1 year+374.0%
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score32
Connections with evidence3

RCEL · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
CS
Crowe SuzanneDirector
RCELAVITA Medical, Inc.
Grant or award
A—
22.2K sh
Jan 20, 2026Jun 4, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Lobbied forevidence
    JEFFREY J. KIMBELL & ASSOCIATES, INC.LDA 1T 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Insider ofevidence
    Crowe SuzanneDirector · Jun 4, 2026
traded Jan 20, 2026
+135d
SEC FORM 4

Evidence

24
CS
Crowe SuzanneDirector
RCELAVITA Medical, Inc.
Grant or award
A—
16.1K sh
Jan 20, 2026Jun 4, 2026
traded Jan 20, 2026
+135dSEC FORM 4

Evidence

Lobbying

$15K reported · de-duplicated
2026 Q1 $15K via firms
  • JEFFREY J. KIMBELL & ASSOCIATES, INC.$15K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.